Elevated Levels of Procoagulant Microvesicles in Patients With Dengue Fever

References

• Bhatt S , GethingPW, BradyOJet al. The global distribution and burden of dengue. Nature, 496(7446), 504–507 (2013).
   PubMed Web of Science ®Google Scholar
• Kholedi AAN , BalubaidO, MilaatW, KabbashIA, IbrahimA. Facteurs associés à la propagation de la dengue dans le gouvernorat de Djeddah (Arabie saoudite). East. Mediterr. Heal. J., 18(1), 15–23 (2012).
   PubMedGoogle Scholar
• Alhaeli A , BahkaliS, AliA, HousehMS, El-MetwallyAA. The epidemiology of dengue fever in Saudi Arabia: a systematic review. J. Infect. Public Health, 9(2), 117–124 (2016).
   PubMed Web of Science ®Google Scholar
• World Health Organization . Dengue guidelines for diagnosis, treatment, prevention and control. (2009). https://apps.who.int/iris/handle/10665/44188
   Google Scholar
• Diamond MS , PiersonTC. Molecular insight into dengue virus pathogenesis and its implications for disease control. Cell, 162(4), 488–492 (2015).
   PubMedGoogle Scholar
• Fernando S , WijewickramaA, GomesLet al. Patterns and causes of liver involvement in acute dengue infection. BMC Infect. Dis., 16(319), 319 (2016).
   PubMedGoogle Scholar
• Nimmannitya S . Clinical spectrum and management of dengue haemorrhagic fever. Southeast Asian J. Trop. Med. Public Health., 18(3), 392–397 (1987).
   PubMedGoogle Scholar
• Hamali HA . The mighty role of platelets in immunity, inflammation, cancer and angiogenesis. Majmaah J. Heal. Sci., 8(1), 65–81 (2020).
   Google Scholar
• Saboor M , AyubQ, IlyasS, Moinuddin. Platelet receptors: an instrumental of platelet physiology. Pakistan J. Med. Sci., 29(3), 891–896 (2013).
   PubMedGoogle Scholar
• Assinger A . Platelets and infection - an emerging role of platelets in viral infection. Front. Immunol., 5(649), 1–9 (2014).
   PubMedGoogle Scholar
• Ogura H , KawasakiT, TanakaHet al. Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis. J. Trauma, 50(5), 801–809 (2001).
   PubMedGoogle Scholar
• Wu MF , ChenST, YangAHet al. CLEC5A is critical for dengue virus-induced inflammasome activation in human macrophages. Blood, 121(1), 95–106 (2013).
   PubMedGoogle Scholar
• Piccin A , MurphyWG, SmithOP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev., 21(3), 157–171 (2007).
   PubMed Web of Science ®Google Scholar
• Berckmans RJ , NieuwlandR, BöingAN, RomijnFPHTM, HackCE, SturkA. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb. Haemost., 85(4), 639–646 (2001).
   PubMed Web of Science ®Google Scholar
• Morel O , TotiF, HugelBet al. Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler. Thromb. Vasc. Biol., 26(12), 2594–2604 (2006).
   PubMed Web of Science ®Google Scholar
• Hamali H , ElhusseinO, JamilA, HussainS, AlshraimM, AlshehriA. Elevated levels of pro-coagulant microvesicles in children in-steady state sickle cell disease. J. Appl. Hematol., 6(3), 115–118 (2015).
   Google Scholar
• Shet AS , ArasO, GuptaKet al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood, 102(7), 2678–2683 (2003).
   PubMed Web of Science ®Google Scholar
• Giesen PLA , RauchU, BohrmannBet al. Blood-borne tissue factor: another view of thrombosis. Proc. Natl Acad. Sci. USA, 96(5), 2311–2315 (1999).
   PubMed Web of Science ®Google Scholar
• Chen ST , LinYL, HuangMTet al. CLEC5A is critical for dengue-virus-induced lethal disease. Nature, 453(7195), 672–676 (2008).
   PubMed Web of Science ®Google Scholar
• Van Niel G , D’AngeloG, RaposoG. Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell Biol., 19(4), 213–228 (2018).
   PubMed Web of Science ®Google Scholar
• Mooberry MJ , KeyNS. Microparticle analysis in disorders of hemostasis and thrombosis. Cytom. Part A, 89(2), 111–122 (2016).
   PubMedGoogle Scholar
• Nomura S , TaniuraT, ItoT. Extracellular vesicle-related thrombosis in viral infection. Int. J. Gen. Med., 13, 559–568 (2020).
   PubMed Web of Science ®Google Scholar
• Hijmans JG , StockelmanKA, GarciaVet al. Circulating microparticles are elevated in treated HIV-1 infection and are deleterious to endothelial cell function. J. Am. Heart Assoc., 8(4), e011134 (2019).
   PubMedGoogle Scholar
• Kornek M , LynchM, MehtaSHet al. Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis. Gastroenterology, 143(2), 448–458 (2012).
   PubMed Web of Science ®Google Scholar
• Puddu P , PudduGM, CraveroE, MuscariS, MuscariA. The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases. Can. J. Cardiol., 26(4), 140–145 (2010).
   PubMedGoogle Scholar
• Barry OP , KazanietzMG, PraticòD, FitzGeraldGA. Arachidonic acid in platelet microparticles up-regulates cyclooxygenase-2-dependent prostaglandin formation via a protein kinase C/mitogen-activated protein kinase-dependent pathway. J. Biol. Chem., 274(11), 7545–7556 (1999).
   PubMed Web of Science ®Google Scholar
• Punyadee N , MairiangD, ThiemmecaSet al. Microparticles provide a novel biomarker to predict severe clinical outcomes of dengue virus infection. J. Virol., 89(3), 1587–1607 (2015).
   PubMed Web of Science ®Google Scholar
• Potts JA , RothmanAL. Clinical and laboratory features that distinguish dengue from other febrile illnesses in endemic populations. Trop. Med. Int. Heal., 13(11), 1328–1340 (2008).
   PubMedGoogle Scholar
• The T , LeThi Thu T, MinhDet al. Clinical features of dengue in a large vietnamese cohort: intrinsically lower platelet counts and greater risk for bleeding in adults than children. PLoS Negl. Trop. Dis., 6(6), e1679 (2012).
   PubMedGoogle Scholar
• Patil R , BajpaiS, GhoshK, ShettyS. Microparticles as prognostic biomarkers in dengue virus infection. Acta Trop., 181, 21–24 (2018).
   PubMedGoogle Scholar
• Ojha A , NandiD, BatraHet al. Platelet activation determines the severity of thrombocytopenia in dengue infection. Sci. Rep., 7(1), 1–10 (2017).
   PubMedGoogle Scholar
• Italiano JE , MairuhuAT, FlaumenhaftR. Clinical relevance of microparticles from platelets and megakaryocytes. Curr. Opin. Hematol., 17(6), 578–584 (2010).
   PubMed Web of Science ®Google Scholar
• Van Beers EJ , SchaapMCL, BerckmansRJet al. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica, 94(11), 1513–1519 (2009).
   PubMed Web of Science ®Google Scholar
• Burton JO , HamaliHA, SinghRet al. Elevated levels of procoagulant plasma microvesicles in dialysis patients. PLoS ONE, 8(8), e72663 (2013).
   PubMedGoogle Scholar
• Sinauridze EI , KireevDA, PopenkoNYet al. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb. Haemost., 97(3), 425–434 (2007).
   PubMed Web of Science ®Google Scholar
• Sung PS , HuangTF, HsiehSL. Extracellular vesicles from CLEC2-activated platelets enhance dengue virus-induced lethality via CLEC5A/TLR2. Nat. Commun., 10(1), 2401 (2019).
   PubMedGoogle Scholar
• Badawi A , VelummailumR, RyooSGet al. Prevalence of chronic comorbidities in dengue fever and west nile virus: a systematic review and meta-analysis. PLoS ONE, 13(7), e0200200 (2018).
   PubMed Web of Science ®Google Scholar
• Berezin AE , KremzerAA, MartovitskayaYV, SamuraTA, BerezinaTA. Pattern of circulating endothelial-derived microparticles among chronic heart failure patients with dysmetabolic comorbidities: the impact of subclinical hypothyroidism. Diabetes Metab. Syndr. Clin. Res. Rev., 10(1), 29–36 (2016).
   PubMedGoogle Scholar
• Berezin A , KremzerA, MartovitskayaY, SamuraT, BerezinaT. The association of subclinical hypothyroidism and pattern of circulating endothelial-derived microparticles among chronic heart failure patients. Res. Cardiovasc. Med., 4(4), e29094 (2015).
   PubMedGoogle Scholar
• Mackman N , TilleyRE, KeyNS. Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis. Arterioscler. Thromb. Vasc. Biol., 27(8), 1687–1693 (2007).
   PubMed Web of Science ®Google Scholar
• Szotowski B , AntoniakS, PollerW, SchultheissHP, RauchU. Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines. Circ. Res., 96(12), 1233–1239 (2005).
   PubMed Web of Science ®Google Scholar
• Ott I . Soluble tissue factor emerges from inflammation. Circ. Res., 96(12), 1217–1218 (2005).
   PubMedGoogle Scholar
• Bogdanov VY , VersteegHH. Soluble tissue factor in the 21st century: definitions, biochemistry, and pathophysiological role in thrombus formation. Semin. Thromb. Hemost., 41(7), 700–707 (2015).
   PubMedGoogle Scholar
• Wills BA , OraguiEE, StephensACet al. Coagulation abnormalities in dengue hemorrhagic fever: serial investigations in 167 Vietnamese children with dengue shock syndrome. Clin. Infect. Dis., 35(3), 277–285 (2002).
   PubMedGoogle Scholar
• De Azeredo EL , KubelkaCF, AlburquerqueLMet al. Tissue factor expression on monocytes from patients with severe dengue fever. Blood Cells Mol. Dis., 45(4), 334–335 (2010).
   PubMedGoogle Scholar
• De Azeredo E , SolórzanoVEF, de OliveiraDBet al. Increased circulating procoagulant and anticoagulant factors as TF and TFPI according to severity or infecting serotypes in human dengue infection. Microbes Infect., 19(1), 62–68 (2017).
   PubMedGoogle Scholar
• Szotowski B , AntoniakS, RauchU. Alternatively spliced tissue factor: a previously unknown piece in the puzzle of hemostasis. Trends Cardiovasc. Med., 96(12), 1233–1239 (2006).
   Google Scholar